Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Spanish reimbursement system

- PMLiVE

New Merck Foundation appoints Rasha Kelej

She takes up role as CEO of the pharma firm's newly-established non-profit

- PMLiVE

Merck & Co’s anacetrapib rescued by positive phase III trial

Data suggests drug reduces MACE compared to placebo

- PMLiVE

GSK starts trial of Nucala to seek alternate indications

Asthma therapy drug to be used to target severe nasal polyposis

- PMLiVE

Delivering ‘accountable marketing’

It’s about time… and data

- PMLiVE

Mobile health and patient outcomes

Putting the humanity back into patient care

Sanofi reception

Sanofi and Regeneron bag EU approval for arthritis drug Kevzara

The IL-6 inhibitor will be used in combination with methotrexate for adults with RA

- PMLiVE

No deal for Stada as private equity takeover bid collapses

65.52% of investors supported the takeover, just shy of the 67.5% needed to close the deal

Digital disruption

How pharma is keeping up with the pace of change

- PMLiVE

ThromoboGenics appoints Thomas Clay as chairman of the board

He moves from his previous position as non-executive director

- PMLiVE

Dr Desiree Luthman joins Verona Pharma

She takes up its vice president position

- PMLiVE

Europe delays EMA relocation decision

Will resolve the issue in November, one month later than expected

- PMLiVE

Shoring up the framework

European regulators add a measure of clarity to pharma’s uncertainty around Brexit

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links